Our trademarks
The words 'Intellia Foods', a UK Registered Trademark application UK00004314133 for classes 1, 5, 29, 30, 30, 31, 40
The word 'UPP', a UK Registered Trademark UK00004132645 for classes 1, 5, 9, 30, 31
The word 'Prota', a UK Registered Trademark UK00004133440 for classes 1, 5, 29, 31. The word 'Prota+', a UK Registered Trademark UK00004313855 for classes 1, 5, 29
The logos above, a UK Registered Trademark UK00004136982 for classes 1, 5, 7, 29, 31, 35, 44
The word 'Harvesta', a UK Registered Trademark UK00004137021 for classes 7, 44
The word 'Intellia', a UK Registered Trademark UK00004137024 for classes 35, 44
The word 'Fiba', a UK Registered Trademark UK00004137025 for class 5 and application UK00004314178 for classes 29 and 30.
The word 'Ova', a UK Registered Trademark UK00004137028 for classes 1, 3, 5, 29
The word 'Ola', a UK Registered Trademark UK00004137030 for classes 1, 5, 29, 30
The word 'Nutra', a UK Registered Trademark UK00004137034 for classes 1, 30 and application UK00004314213 for classes 5,29,30
The word 'Necta', a UK Registered Trademark UK00004137035 for classes 1, 5, 30
The word 'Bia', a UK Registered Trademark UK00004137037 for class 1
The word 'Reacta', a UK Registered Trademark UK00004137041 for classes 1, 9, 10, 11
The word 'Binda', a UK Registered Trademark application UK00004313869 for classes 1, 30, and the word 'Bynda', a UK Registered Trademark UK00004340111 for classes 1, 30.
The word 'Matra', a UK registered Trademark UK00004313863 for classes 1, 5, 29
The word 'Myca', a UK Registered Trademark UK00004313857 for classes 1, 5, 29, 30, 31
The word 'Ita', a UK Registered Trademark UK00004313892 for classes 1, 5, 29, 30, 31
The word 'Ota', a UK Registered Trademark UK00004313893 for classes 1, 5, 29, 30, 31
The word 'Isa', a UK Registered Trademark UK00004313895 for classes 1, 5, 29, 30, 31
Intellectual Property ('IP') is seen as core to value creation and defensibility, and its management is overseen by the CEO (an inventor on 15 patent families), reassessed annually in Q4, and reviewed by the board. Our IP approach is commercially driven and focussed on defensibility, and primarily based on the assets of patents, know-how and trade secrets. In terms of patents, there is currently:
One family granted in the UK: GB2608367 and published in the US and EU
One additional family published in the UK: GB2641578
One further family filed in the UK: GB2610712.8
More imminent with further expected.
Patent development and filing constitutes the majority of IP-related costs. We protect trade secrets through a combination of process compartmentalisation, restricted access to critical know-how, contractual confidentiality with employees and partners, and deliberate decisions to retain key process parameters and operational learnings outside of patent filings. Trademarks are a subsidiary part of our IP, supporting commercialisation, partnerships, and velocity, rather than constituting the core "moat". All IP is the property of the Company.
Our brand architecture is tiered: a corporate/master brand ('Tier 1'), a small number of externally visible commercial brands ('Tier 2'), and a larger set of dormant or internal roadmap brands ('Tier 3'). The roadmap marks are defensive placeholders; we do not build identity systems, packaging, or marketing behind them until revenue-linked. At any time, we cap externally active brands to minimise confusion, and we will prune non-core brands unless tied to revenue or regulatory pathways. The brand architecture is designed to reflect that our primary revenue driver is ingredient sales, the secondary revenue driver is equipment leasing/sales/data services and that there is a tertiary option of licensing.
Our supporting trademark strategy is to take a staged, capital-efficient approach aligned to commercial deployment. As a B2B business we are keenly aware that brands exist to protect partnerships and revenue, and are not an end in themselves - trademarks are options, not trophies, and not activated until they impact revenue. However, food is a crowded domain in terms of brands, and so it requires forethought to deliver a coherent and distinctive identity across the broad range of opportunities that we could access and, most importantly, reduce the risk of being forced to re-brand.
Our core ingredients are non-novel foods so our commercial timelines are governed by customer qualification and operational ramp, not by regulatory approval. This is a structural difference between us and most companies marketed as 'alternative protein', and it is why our activation calendar was and remains viable. We highlight that Fiba, Bynda, Prota and Necta are all fractions of broccoli from a single line but release was phased to manage operational complexity.
Tier 2 trademarks pertaining to revenue-generating ingredients (Fiba™, Prota™), the key cost-defining technology (Harvesta™) and the data offer (Intellia™) have been used externally in trade (customer/partner materials, datasheets, and website) since 2024. Commercial shipments under Fiba began in 2025, Bynda has been marketed and sold from Q1 2026. We expect 'Prota' to follow in mid-2026 and 'Necta' from late-2026.
We first contracted Harvesta in early 2026 and expect to deploy Intellia from 2027. From 2025 we have had initial discussions as to licensing our full technology stack outside of Europe and the US, and for this reason 'Bia' and 'Reacta' have been adopted to frame the processes we would license beyond the Harvesta equipment.
We have also filed trademarks around intended product and platform segmentation where brand conflict could be costly, but we are activating these narrowly to avoid dilution of effort. Where possible, we have filed marks with broad class coverage (e.g., multiple adjacent classes in foods/supplements) as part of intentional 'future-proofing'. Non-core marks will be periodically reviewed and allowed to lapse unless tied to an active commercial or regulatory path.
Tier 3 trademarks include a small set of filed roadmap marks across by-products and new feedstocks, extend beyond those currently used, and are intentionally not activated until commercially launched. Our view is filing early, with trademarks covering primary elements of the long-term product roadmap, preserves optionality at low cost: Filing to ensure unfettered brand development before launch is cheap; quickly rebuilding brands post-launch after conflict is expensive and distracting. Thus, well-considered, limited and controlled up-front trademark expenditure manages and reduces future risk. We monitor trademarks for lapse, but our earliest trademarks are not due for renewal until 2034 and we will evidence usage to prevent "non-use" challenges that could potentially arise from 2029.
For instance, we are working with partners to trial our 'Necta' as a low-cost mycelium feedstock that shows potential for nutrient uptake in to the mycelium, and have trademarked around both mycelium from broccoli substrate ('Myca') and the use of Fiba as a scaffold or 'matrix' ('Matra') that adds texture/mouthfeel. Matra would potentially add nutritional benefits to mycelium-hybrid food products, as well as reducing total ingredient cost to (for instance) allow mycelium burgers to compete with beef burgers.
We highlight that we are not "frontier alt-protein"; we are "feedstock architects" delivering an optimised platform that others plug into - we support fermentation players rather than compete with them. Matra/Myca are an example of how trademarks can be used as boundary-setting tools for joint development as well as how we focus on turning roadmap items into value. We do not expect Myca and Matra to be activated until 2027/28 as mycelium-based products currently generally require clearances as 'novel foods', and this takes extended time. We do not currently pursue strain-specific patent claims in mycelium-based systems or precision fermentation, as our strategy prioritizes collaborative partnering over competitive strain ownership. If mycelium economics or regulatory complexity threaten to contaminate our core ingredient platform, we will stop at feedstock supply.
'Ova’ is being used for initial marketing of a protein fraction/by-product from one of our processes. Early testing suggests it can deliver emulsification functionality as a vegan replacement for egg in some formulations and applications. We do not expect Ova to be sold at commercial scale until 2027 or later.
As a further example, we have tested cauliflower in the same process used for broccoli, and it performs well at material concentrations in certain foods, and this product set is branded as 'Ola'. Ola is gated on having multiple lines operational (expected 2027), to avoid disrupting broccoli-feedstock production. Other brands ('Isa', 'Ota') pertain to other feedstocks that we reasonably believe are likely to work in the same process (or with limited modification). 'Ita' is reserved to brand broccoli-based products once there are non-broccoli-based products being marketed. Because our timelines are commercial rather than regulatory, we expect to use these trademarks before 2029 and do not expect to face non-use challenges.
We actively monitor our registered and pending trademarks through periodic reviews and will use third-party watch services, with a focus on protecting marks that are actively deployed or commercially material. We aim to ensure our trademarks function as effective boundary-setting and value-protection tools without becoming a source of unnecessary cost or distraction. We have not needed to enforce any rights to-date.
To date, we have prioritised UK filings to preserve priority dates while remaining capital efficient. International filings (EU/US) for core marks (Prota, Fiba, Harvesta) are planned via Madrid or direct filings as part of planned market expansion. In the US, we will use Intent-to-Use filings for the USPTO for 4-5 filings, to hold priority during technical and regulatory lead times. Conversion to use-based registration will follow first US commercial shipments.
If/when conflicts arise, we will apply a proportional response ladder: (1) narrow classes/specification and adjust branding hierarchy where non-material, (2) negotiate coexistence/consent where commercial risk is low and confusion can be contractually managed, (3) rebrand non-core marks when cheapest, and (4) formal opposition/enforcement where a Tier 2 mark is revenue-linked or reputationally material.
We have contingency naming at Tier 1 ('Freya' [www.freya.food] and 'Intellia Foods' [www.intelliafoods.com]). This was put in place after the book 'Ultra Processed People' (a critique of the food industry reviewed in the New York Times, and a bestseller) had potentially compromised the initials 'UPP' as a food-related brand, even though the Company is very much a proponent of healthier, minimally-processed food and ingredients. This paves the way for a potential separation of the brands and websites of the business from the products/services (food ingredients and harvest services).
In summary, we have taken a staged, capital-efficient approach: actively deploying only trademarks that are tied to revenue, while selectively filing around key roadmap "lanes" to preserve optionality and reduce future risk. This approach mirrors the discipline seen in later-stage platform companies, but is being implemented earlier relative to capital raised. As a result, we are delivering clearer partnership boundaries and lower future rebranding risk than most peers.
The word 'Freya', a UK Registered Trademark UK00004066737 for classes 1, 5, 29, 31, 32
Intellectual Property strategy
Get in touch
© 2026. All rights reserved.
Upcycled Plant Power ('UPP') Limited
trading as "UPP" and "Freya"
Company number: 14171122
VAT Number: 428 2222 17
Registered address:
Agri-Tech Centre
Poultry Drive, Edgmond,
Newport, Shropshire
United Kingdom TF10 8JZ
Connect with us
Broccoli is a natural source of vitamin K and contains folate, potassium and beta-carotene, a provitamin A carotenoid. Our Fiba, Bynda and Prota products are a source of fibre, making them nutritionally valuable ingredients.
"Allergen-free" refers to the absence of the 14 allergens requiring declaration under UK/EU FIC. See here for our Allergen statement.
+44 1952 327 357
